Close Menu

Hitachi

Panasonic of Osaka, Japan, has received US Patent No.

The Biological Research Center of the Hungarian Academy of Sciences and Glaxo Group Limited, a subsidiary of GlaxoSmithKline, have been jointly awarded US Patent No. 8,389,802, "Artificial chromosomes, uses thereof, and methods for preparing artificial chromosomes.

FIO of Toronto has received US Patent No.

Corbett Research has been awarded US Patent No. 8,271,205, "Method and system for analysis of melt curves, particularly dsDNA and protein melt curves."
Valin Reja, Alister Kwok, and Glenn Stone are named as inventors on the patent.

NEW YORK (GenomeWeb News) – Hitachi Asia and Data Storage Institute today announced an extension of a collaboration to develop a data compression technique in order to manage the ever-growing amount of genomic sequencing data.

Samsung Electronics has been awarded US Patent No. 8,185,324, "Method of determining initial concentration of nucleic acid in sample using real-time amplification."
Kak Namkoong, Young-sun Lee, Chin-sung Park, and Joo-won Rhee are named as inventors on the patent.

Hitachi of Tokyo has received US Patent No.

Fluidigm of South San Francisco, Calif., has received US Patent No.

US Patent 8,131,473. Data analysis methods for locating entities of interest within large, multivariable datasets. Inventors: Marie Coffin, Keith Allen, Brian Bullard, Alan Higgins. Assignee: Metabolon

US Patent 8,116,988. Method for indexing nucleic acid sequences for computer based searching. Inventors: Benjamin Glick, William Stokes. Assignees: The University of Chicago, GSL Biotech

Pages

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.